Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib may help treat hair loss in children with alopecia areata.

α-Tocopheryl acetate is well absorbed through healthy skin.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

A patient with complete hair loss regrew all her hair using tofacitinib.

The combination therapy was effective and well-tolerated, especially in young patients.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

OCT is a reliable, noninvasive way to measure hair thickness.

Optical coherent tomography can effectively detect steroid use by analyzing hair changes.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.